Journal Article

Latest additions:
2026-06-10
10:33
DBCoverage [DZNE-2026-00603] Journal Article
; ; ; et al
Human Coronavirus 229E Uses ORF4/4a to Antagonize the Host Restriction Factor SERINC5.
MedComm 7(6), e70785 () [10.1002/mco2.70785]
Serine incorporator 5 (SERINC5) restricts the infectivity of various enveloped viruses, including HIV-1 and severe acute respiratory syndrome coronavirus 2. However, these pandemic viral pathogens have evolved mechanisms to counteract this restriction. [...]
Restricted: Download fulltextPDF Download fulltextPDF (PDFA);

Detailed record - Similar records
2026-06-10
10:32
[DZNE-2026-00602] Journal Article
; ; ; et al
Depletion of Neurocan in the Prefrontal Cortex Impairs Temporal Order Recognition, Cognitive Flexibility and Perisomatic GABAergic Innervation.
The condensed form of the neural extracellular matrix (ECM), known as perineuronal nets (PNNs), is predominantly associated with parvalbumin-expressing (PV+) interneurons in the cortex and hippocampus. PNNs are enriched in lecticans, including neurocan (Ncan). [...]
Restricted: Download fulltextPDF Download fulltextPDF (PDFA);

Detailed record - Similar records
2026-06-10
10:27
[DZNE-2026-00601] Journal Article
; ; ; et al
ApoE4 lowers the ptau217 threshold for tau aggregation and spread in an allele dose-dependent manner.
Brain 149(6), 1902 - 1914 () [10.1093/brain/awaf463]
In Alzheimer's disease, carriage of the apolipoprotein E ε4 (ApoE4) risk allele is linked to faster tau accumulation at lower amyloid-PET levels, thereby accelerating disease progression. However, it remains unclear whether this ApoE4-facilitated transition from amyloidosis to tauopathy is mechanistically promoted by increased secretion of phosphorylated tau (ptau), a key intermediate that drives the amyloid-to-tauopathy transition, or alternatively by increased ptau-driven tau aggregation. [...]
Fulltext: Download fulltextPDF Download fulltextPDF (PDFA);

Detailed record - Similar records
2026-06-08
15:55
DBCoverage [DZNE-2026-00600] Journal Article
; ; ; et al
Efficacy and safety of donanemab in the European eligible population: TRAILBLAZER-ALZ 2 post-hoc analyses.
In the European Union (EU), donanemab is indicated in adults with early symptomatic Alzheimer's disease who are apolipoprotein E ε4 non-carriers or heterozygotes. Among these, patients without superficial siderosis at baseline, uncontrolled hypertension, or anticoagulant use are eligible.To assess efficacy and safety of donanemab in the EU-eligible population.A post-hoc conservative hybrid imputation method was implemented for clinical efficacy analyses during the TRAILBLAZER-ALZ 2 placebo-controlled period. [...]
Restricted: Download fulltextPDF Download fulltextPDF (PDFA);

Detailed record - Similar records
2026-06-08
15:53
[DZNE-2026-00599] Journal Article
; ; ; et al
EXOSC10 haploinsufficiency causes primary microcephaly by derepression of Sonic hedgehog signalling.
Brain 149(6), 2072 - 2090 () [10.1093/brain/awaf405]
The evolutionarily conserved RNA exosome complex modulates gene expression during development. Mutations in RNA exosome complex subunits have been implicated in various human brain disorders, suggesting that defects in RNA decay are linked to impaired neural development. [...]
Fulltext: Download fulltextPDF Download fulltextPDF (PDFA);

Detailed record - Similar records
2026-06-08
15:51
[DZNE-2026-00598] Journal Article
; ; ; et al
Differential associations of plasma biomarkers with Alzheimer's disease and small vessel disease: A multimodal imaging study.
We investigated how plasma biomarkers (phosphorylated tau 217 [ptau217], glial fibrillary acidic protein [GFAP], neurofilament light chain [NfL]) relate to imaging markers of small vessel disease (SVD) and Alzheimer's disease (AD), and cognition in memory clinic patients.76 memory clinic patients underwent plasma biomarker assessment, neuropsychological testing, and 3T MRI. SVD burden was assessed using white matter hyperintensity (WMH) volume, mean skeletonized mean diffusivity (MSMD), and fiber density. [...]
Restricted: Download fulltextPDF Download fulltextPDF (PDFA);

Detailed record - Similar records
2026-06-08
15:39
[DZNE-2026-00597] Journal Article
; ; ; et al
Tongue volume in spinal and bulbar muscular atrophy (SBMA): an AI-assisted automatic MRI analysis.
Atrophy of the tongue muscle without severe dysarthria is one of the clinical hallmarks of spinal and bulbar muscular atrophy (SBMA), a motor neuron disease caused by an androgene receptor defect. An operator-independent AI-based automatic segmentation of the tongue was applied to 3-D MRI data of the head in SBMA in order to quantify the tongue atrophy. [...]
Restricted: Download fulltextPDF Download fulltextPDF (PDFA);

Detailed record - Similar records
2026-06-08
15:36
pmc [DZNE-2026-00596] Journal Article
; ; ; et al
Longitudinal Non-interventional Changes of the FORTA Score are Associated with Changes of Cognitive and Physical Function Tests in Community-Dwelling Older People.
Drugs & aging 43(6), 507 - 516 () [10.1007/s40266-026-01301-0]
Listing tools were found to ameliorate drug treatment in older people; the FORTA (Fit-fOR-The-Aged) list is a clinically validated positive-negative list of medication appropriateness. Here, we retrospectively analyze longitudinal correlations between the FORTA score and key measures of physical and cognitive function in older people.504 participants of a multi-center cohort study (AgeCoDe/AgeQualiDe) for whom the FORTA score (sum of over- and under-treatment errors) had been assessed were studied at three follow-up (FU) time points (FU 6-8; mean age range 87.9-89.7 years); comparisons between data at these FUs separated by 10 months were available for 292-328 patients.The univariate analysis of the association between FORTA_Delta_76 (change of FORTA score between FU 6 and 7) and ADL (Activities of Daily Living)_Delta_76 (- 0.155, p < 0.01) and between FORTA_Delta_76 and MMSE (Mini-Mental State Examination)_Delta_76 (- 0.203, p < 0.01) revealed significant correlations. [...]
Restricted: Download fulltextPDF Download fulltextPDF (PDFA);

Detailed record - Similar records
2026-06-08
15:31
[DZNE-2026-00595] Journal Article
; ; ; et al
Quality of Life in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.
Muscle & nerve 74(1), 59 - 67 () [10.1002/mus.70232]
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare disorder of the nervous system that detrimentally influences health-related quality of life (HRQoL). Evidence regarding factors influencing HRQoL in CIDP is scarce. [...]
Restricted: Download fulltextPDF Download fulltextPDF (PDFA);

Detailed record - Similar records
2026-06-05
16:44
DBCoverage [DZNE-2026-00594] Journal Article
; ; ; et al
The epitranscriptomic m6A RNA modification modulates the synapse in ageing and in a mouse model of synucleinopathy.
N6-methyladenosine (m6A) is the most abundant transcriptional modification in eukaryotic RNA, regulating RNA fate. While the functions of m6A in the development of the mammalian brain have been extensively studied, its role in synaptic plasticity, and brain function remain underexplored. [...]
Restricted: Download fulltextPDF Download fulltextPDF (PDFA);

Detailed record - Similar records